Please provide your email address to receive an email when new articles are posted on . “The cell-free DNA is the first blood-based test with performance that is comparable to current guideline ...

Cancer’s genetic fingerprints may lurk in people’s blood long before they find out about the disease. It’s possible to spot tumor DNA more than three years before a person is diagnosed with cancer, ...

Cancer continues to be one of the world's top causes of death, partly because of delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to ...

A novel blood test analyzing fragments of cell-free DNA showed robust diagnostic performance for colorectal cancer across clinical subgroups, offering a promising noninvasive screening method.

Researchers are reporting progress on a blood test that can detect multiple cancers in a relatively simpler, and potentially less pricey, way than other tests under development. The test picks up ...

At a time when colorectal cancer is on the rise, a new study finds the disease can be detected through a blood test. The results of a clinical trial, published Wednesday, in The New England Journal of ...

A cell-free DNA (cfDNA) blood test, aimed at detecting abnormal DNA signals in people with an average risk of colorectal cancer (CRC), correctly detected CRC in most people confirmed to have the ...

The Shield blood test developed by Guardant has been approved by the FDA as a primary screening option for colorectal cancer, providing a more convenient method of screening. Guardant’s Shield blood ...

A new blood test to screen for colon cancer was approved Monday by the Food and Drug Administration (FDA), aimed at finding cancer when it’s still in the early stage and treatable. The blood test, ...